KP Division of Research Cancer Section

Our studies are designed to identify the best ways to prevent, screen, detect, diagnose, and treat cancer and improve the quality of life of cancer survivors.

[Kaiser Permanente Research NorCal @KPDOR]

Nice to have @BeckersHR report on study in @AnnalsofIM led by @tr_levin @JeffLeeMD @KPDOR @kpnorcal @PermananetDocs & @KPWaResearch @KPSCalResearch on FIT completion, cancers when #colorectalcancer screening starts at age 45.

Story: https://t.co/rsw1qLNAQd

[Kaiser Permanente Research NorCal @KPDOR]

Did you know? Up to 1/3 of #lungcancer diagnoses occur in the #emergencydepartment. @meera_ragavan @kpnorcal @PermanenteDocs & colleagues research presented at #WCLC24 sought to determine who these patients were. @KPCancerRsrch #lcsm

[Kaiser Permanente Research NorCal @KPDOR]

Now in @JGeriOnc: @melisawongmd @kpnorcal @PermanenteDocs @KPCancerRsrch & colleagues find about 1/2 of older adults with advanced #NSCLC #lungcancer who lived alone maintained their function, cognition, and #qualityoflife during treatment. #lcsm

Study: https://t.co/5YJXchsX4x

[Kaiser Permanente Research NorCal @KPDOR]

Great to read @DouglasCorley @KPDOR @kpnorcal @PermanenteDocs perspective on this @JAMANetworkOpen study on #cancer incidence trends in the U.S. in this story by @ronnielcohen for @NPRHealth. @KPCancerRsrch
#cancerresearch #cancerprevention

Story: https://t.co/N0vwOGCkDI

[Kaiser Permanente Research NorCal @KPDOR]

ICYMI: Our story on this research: https://t.co/l9iHJvUr5V
#mammography #DCIS #breastcancer #bcsm
@NCCN @KPCancerRsrch @kpnorcal @PermanenteDocs @Rayliukpsfo

[Kaiser Permanente Research NorCal @KPDOR]

At #ASCO24 @ASCO: Research led by @RoswellPark @KPDOR using data from the @kpnorcal Pathways Study finds a polygenic risk score has the potential to predict survival outcomes in patients with #breastcancer. Oral Abstract 10502; Sat. June 1. #bcsm

Story: https://t.co/5U4TKXFejU

[Kaiser Permanente Research NorCal @KPDOR]

“#Coloncancer is the 2nd leading cause of #cancer death in US ... so any test that can make it easier for people ... is a big deal.” @DouglasCorley @kpnorcal @PermanenteDocs tells @camerokt_ @SELFmagazine

Story: https://t.co/cyzZXpmyom

[Kaiser Permanente Research NorCal @KPDOR]

Is it #ovariancancer? In women 50+, if ovarian cyst is stable for 6 wks, risk of #ovariancancer <1 %; stable for 1 yr, risk <1 in 1000. Study led by gyn/onc @KPDOR @kpnorcal @PermanenteDocs Betty Suh-Burgmann in @AJOG_thegray. #WomensHealth

Story: https://t.co/Z3bHa9QVc8

[Kaiser Permanente Research NorCal @KPDOR]

Great to see @DouglasCorley @KPDOR @kpnorcal @PermanenteDocs quoted in this @AP story by @CarlaKJohnson on an @NEJM study on a new blood test to screen for #colorectalcancer. @KPCancerRsrch
#cancerscreening

https://t.co/FB4la81coy

[Jeff Lee @JeffLeeMD]

It's official! Grateful to be an official @theNCI Cancer Screening Research Network site and to evaluate novel cancer screening technologies. Our first trial will test whether #MCDs can detect early cancers and save lives. @kpnorcal @KPDOR @Realcecum @MariaAnsariMD @srouillardmd

[Kaiser Permanente Research NorCal @KPDOR]

Spread the word! Sat. 2/24: Lung Cancer Prevention seminar in #Sunnyvale in #MandarinChinese & English for #Asian communities on #lungcancer risk & screening. Led by @KPDOR @kpnorcal @PermanenteDocs @LoriSakoda @JVelottaMD @StanfordMed @StanfordHealth.

[Kaiser Permanente Research NorCal @KPDOR]

Hear @KPDOR's @tr_levin discuss how @kpnorcal @PermanenteDocs approach to #colorectalcancer screening via stool-based testing is getting more people screened. @KPCancerRsrch
https://t.co/C2T8Wrdm3A via @YouTube from @VJOncology

[ACS Journal Cancer @JournalCancer]

Among patients with #ColonCancer, results from this new study do not support home-based resistance training as an adjunct to chemotherapy specifically to improve planned treatment intensity.

https://t.co/uiRHgHcVx7

@OncoAlert
@KPDOR
@fitaftercancer
#ExerciseOncology
#GI24

[Kaiser Permanente Research NorCal @KPDOR]

Kudos to @KPDOR @kpnorcal @KPCancerRsrch research scientists Laurie Habel, @marilyn_kwan @LoriSakoda whose studies were selected as 2023 Research Highlights by @theNCI Epidemiology and Genomics Research Program!
See the full list of selected papers here: https://t.co/X39nDKIV1T

[KP Division of Research Cancer Section @KPCancerRsrch]

New results out today from the FORCE trial on home‐based resistance training on chemotherapy relative dose intensity and tolerability in colon cancer. In
@JournalCancer at https://t.co/IQAEKE6lor…

@KPDOR #CancerResearch #ColonCancer

[Kaiser Permanente Research NorCal @KPDOR]

Great presentation from @tr_levin on #colorectalcancer screening and his research and experience at @KPDOR @kpnorcal @PermanenteDocs @KPCancerRsrch.

[Kaiser Permanente Research NorCal @KPDOR]

Important findings at #ASCOQLTY23 from @Rayliukpsfo & his @KPDOR @kpnorcal @PermanenteDocs @KPCancerRsrch colleagues on impact of 4R #oncology model on timing, sequence of care for #breastcancer & #lungcancer patients. #cancerresearch #bcsm

More: https://t.co/Ufqb5MQfU7

[Kaiser Permanente Research NorCal @KPDOR]

Check out our new #KPResearchRadio #podcast! In this episode we speak with @KPDOR @kpnorcal @KPCancerRsrch's Bette Caan and Elizabeth Feliciano who study #bodycomposition & #cancersurvivorship. #BreastCancerAwarenessMonth #BCSM #CancerResearch

Listen in: https://t.co/doUbikYMOL

[Kaiser Permanente Research NorCal @KPDOR]

Great @AJMC interview with @JVelottaMD on his @KPDOR @kpnorcal @KPCancerRsrch studies with @LoriSakoda that show increasing #lungcancer rates in female, #Asian, never smokers. #cancerresearch #Cancer

https://t.co/grrcRPXkWM

[KP Division of Research Cancer Section @KPCancerRsrch]

Hot off the press @CCR_AACR: Female patients with advanced soft tissue sarcoma may have worse prognosis compared to male patients, according to the team of @KPCancerRsrch and Stanford sarcoma researchers. @KPDOR

Article link: https://t.co/Cgur6sZI81